A new aminosugar named nojirimycin B (1) has been isolated as its bisulfite adduct from the culture broth of Streptomyces lavendulae SF-425, together with nojirimycin.
Microbial glycosidase inhibitors have been the subject of extensive investigations1), of which nojirimycin was the first inhibitor isolated2). This was followed by isolations of acarbose1,3), 1-deoxynojirimycin4,5), valienaminee), oligostatin7), valiolamine8), etc. These inhibitors are all sugar analogs containing nitrogen in their molecules.
In this paper, we report a new nitrogen containing sugar analog, nojirimycin B* and its oxidation product, D-mannonic-5-lactam, both of which showed potent inhibitory activity against glycosidases.
Preparation of Nojirimycin B and D-Mannonic-b-lactam
Nojirimycin B (1) was co-produced with nojirimycin by Streptomyces lavendulae SF-425. Both antibiotics were isolated from the fermentation broth by the use of Amberlite IR-120 resin and Dowex 1X2 resin. Separation of two antibiotics was achieved by fractional crystallization of bisulfite adducts, and nojirimycin B bisulfite adduct (la) was crystallized after most of nojirimycin bisulfite adduct were recovered. A free base of 1 was prepared by treating la with barium hydroxide. On paper chromatography developed with a mixed solvent of BuOH -pyridine -H,O, 6: 4: 3, 1 free base showed Rf value of 0.36, while la and nojirimycin showed Rfs of 0.13 and 0.25, respectively. However, the preparation of 1 contained a small amount of an unknown substance with Rf 0.27, which was probably derived from spontaneous decomposition of 1 and was difficult to remove. (two ring protons)). These results suggested that 2 was a tetrahydroxypiperidin-2-one.
The stereochemistry of 2 was elucidated by X-ray crystallographic analysis as follows. pBromophenylsulfonylation of 2 with sulfonyl chloride in pyridine at 60°C, followed by acetylation gave monoacetyl-mono p-bromophenylsulfonate (4), mp 185°C. A single crystal was prepared from chloroform-carbon tetrachloride, and its crystal data are shown in Table 1 . By tracing the sulfonylation reaction by the use of TLC and 1H NMR spectroscopy, it was found that the initial product formed was the 2, 6 -di -O-p -bromophenylsulfonate, which was converted into the 3,6-anhydro derivative (4), even under ice-cooling condition. Assuming that the 3,6-anhydro bridge was formed by intramolecular nucleophilic attack of C(3) hydroxyl group to C(6) that bore the leaving sulfonyloxy group, the configuration at C(3) in 2 could be assigned to L. This was confirmed by the direct X-ray analysis of 2.
A single crystal of 2 was prepared from aqueous ethanol, and its crystal data are shown in Table 1 .
The framework of 2 determined by X-ray analysis is shown in Fig. 3 . The relative configurations of hydroxyl groups at C(2), C(3), C(4) and C (5) Determination of Structure of 1
The fact that 1 was transformed to 2 in reasonable yield by microbiological oxidation suggested the 5-amino-5-deoxy-D-mannose structure for 1. This was confirmed by 1H NMR analysis of la shown in Table 2 . Large J3,4 and J4,5 values are consistent with trans-diaxial orientation of H(3), H(4) and H(5). Moderate J2,3 value indicated the equatorial orientation of H (2) . These values were in agreement with those of mannopyranose of C, conformation.
The anomeric H(1) appeared as only one signal, indicating the predominant presence of an epimer, but it was difficult to determine the configuration of H(l) from J,,2 value, because of the equatorial orientation of H (2) proton.
Inhibitory Activities of 1, la and 2 against Three Glycosidases Table 3 shows the inhibition constants (K) for la and 2 against apricot emulsin and rat epididymal a-mannosidase, together with the Km values for the substrates employed. All of the Ki values were substantially small, although the substrates had relatively favorable K values. The LINEWEAVER-BURK plots, from which these values were obtained, showed the inhibition to be competitive in each cases. Table 4 shows the 50 % inhibitory concentrations of 1, la, 2, 5 and 1-~-D-glucosylamine10) against the above two glycosidases and Trichoderma viride (3-glucosidase. The inhibitory activity of 1 was potent against apricot emulsin and amannosidase but less active against Trichoderma 5-glucosidase. Notably, la was two-to five-fold more potent than the parent 1 against these enzymes. The lactam (2) was even more active than la against apricot emulsin, but was less active against a-mannosidase and no activity against Trichoderma p-glucosidase. When compared with the corresponding gluconolactam (5), 2 was 10-to 100-fold more active than 5 against emulsin and amannosidase but less active against Trichoderma p-glucosidase. In contrast, 1-p-D-glucosylamine used as a reference compound showed more potent activity against Trichoderma p-glucosidase than apricot p-glucosidase. Nojirimycin B (1) showed weak activity against Xanthomonas oryzae on paper disk assay (inhibition zone 23.9 mm at 500 pg/ml), but no activity against other bacteria. Table 4 . Comparative inhibitory activities of nojirimycin B (1), its bisulfite adduct (1a), n-mannonic-Slactam (2), n-gluconic-S-lactam (5) and 1-p-n-glucosylamine against apricot p-glucosidase, Trichoderma p-glucosidase and rat epididymal a-mannosidase. The first group has a nitrogen in the ring, and the second group a nitrogen outside of the ring. They may be regarded as isosters of the ring oxygen and the glycosidic oxygen, respectively. Nojirimycin, 1-deoxynojirimycin and D-gluconic-8-lactam belong to the first group, whereas 1-glycosylamines10) and probably acarbose, oligostatin, valienamine, valiolamine belong to the second group.
Nojirimycin B (1), its bisulfite adduct (1a) and D-mannonic-3-lactam (2), new members of the first group, are characterized by a D-mannose configuration. They showed potent inhibitory activity not only against rat epididymal a-mannosidase but also against apricot B-glucosidase.
Notably, the lactam (2) is one of the most potent inhibitors against apricot emulsin so far reported.
Two interesting observations are made on the structure-activity relationships of nojirimycin B and its derivatives against apricot emulsin. First, the configuration at C(2) appears not to be important for the inhibitory activity against this enzyme, since nojirimycin B possessing the D-mannose configuration is comparable or slightly superior in activity to nojirimycinly possessing the D-glucose configuration.
Second, compound 2 with the twist-boat conformation showed more potent activity than did 1 with the chair conformation or 5 with the half-chair conformation12). This is worth noting, since this is not consistent with the half-chair ring form of inhibitors postulated as transition-state analogs13, 14) On the other hand, la and 2 showed only slight inhibitory activity against Trichoderma p-glucosidase, while 1-B-n-glucosylamine was more active against Trichoderma p-glucosidase than against apricot emulsin, indicating different modes of inhibitory action between two types of enzyme inhibitors.
The most potent inhibitor of a-mannosidase is compound 1. Its bisulfite adduct (1a) and its lactam (2) are one-order of magnitude less active, as judged from the 50% inhibition concentration. Here, the importance of the substrate analogy including configurations at C(l) and C (2) is indicated for the inhibitory activity.
These results suggest that nojirimycin B and its lactam would be useful tools for study on the mode of action of various glycosidases. Melting points were determined with a Yamato capillary apparatus. Optical rotations were obtained with a Perkin-Elmer 141 polarimeter, UV spectra with a Hitachi 323 spectrometer, and IR spectra in KBr disks with a Hitachi 215 spectrometer.
1H NMR spectra at 100 MHz were recorded on a Varian XL-100 spectrometer, and mass spectra on a Hitachi M-80 spectrometer.
TLC was carried out by using silica gel plates F,5, (E. Merck). Spots were detected by spraying with 10% sulfuric acid.
Isolation of 1 Streptomyces lavendulae SF-425 was fermented using a 300-liter fermentor according to the procedure previously reported15). The culture filtrate (150 liters) was applied onto a column of Amberlite IR-120 resin (H form, 15 liters). After washing with H2O, the column was eluted with 0.5 N NH,OH. The eluate was assayed for the inhibitory activity against apricot emulsin16). The bioactive fractions (30 liters) were concentrated to 2 liters, and was applied onto a column of Dowex 1X2 resin (OH form, 2 liters). The column was developed with H,O. The bioactive fractions were combined, and concentrated to 570 ml, to which EtOH (230 ml) was added. Sulfur dioxide gas was slowly introduced under ice-cooling until nojirimycin bisulfite adduct crystallized out. The crystals (116 g) were separated, and the mother liquor and washings were combined, and concentrated to 290 ml, from which another crop (14.4 g) of nojirimycin bisulfite adduct was crystallized.
Concentration of the mother liquor and subsequent bubbling with sulfur dioxide afforded crystals of nojirimycin B bisulfite adduct (1a) (12. A free base of 1 was prepared from la as follows. A mixture of la (5.2 g) and an equivalent amount of Ba(OH), in H,O (150 ml) was stirred for 1 hour at room temp. The supernatant was saturated with CO, gas, and precipitates were removed by centrifugation.
The supernatant was passed through a column of Dowex 1X2 resin (OH form, 50 ml), and the effluent was lyophilized to yield a pale yellow powder of 1 (3.4 g).
Preparation of 2 from 1 by Microbial Oxidation G. suboxydans IAM 1829 was cultivated at 28°C for 42 ~ 50 hours using a medium consisting of sucrose 2 %, peptone 0.5 %, yeast extract 0.2 %, sodium glutamate 0.2 %, K2HPO4 0.2 %, CaCl2 0.01 and FeSO4 0.001 %. The washed cells (wet weight, 100 mg) thus obtained were added to 2 % aqueous solution of 1 (200 mg) in 0.05 M phosphate buffer, pH 7.5. The suspension was shaken at 28°C for 5 hours. After centrifugation, the supernatant was subjected to a column chromatography over active carbon (30 ml) developed with H,O. The effluent was assayed for inhibitory activity against apricot emulsin16). The active fractions were concentrated to give crystals of 2 (96 mg).
A large quantity of 2 was obtained from the crude preparation of nojirimycin containing 1 as follows. An aqueous solution of 2 % crude nojirimycin (30 g) in 0.05 M phosphate buffer (pH 8.0) was incubated with the washed cells of G. suboxydans IAM 1829 (60 g) at 28°C for 5.5 hours in a 30-liter jar fermentor with an air flow rate of 0.5 vol/vol/minute. After centrifugation, the supernatant was successively passed through columns of Amberlite IR-120 (H form, 3 liters) and Amberlite IR-45 (OH form, 3.8 liters), and the active effluents were concentrated to crystallize 5 (18.7 g) that was derived from nojirimycin. The mother liquor was concentrated to a small volume, and applied onto a column of activated carbon (5. 
X-Ray Analysis
Three dimensional intensity data were collected using a Philips PW-1100 automatic four-circle diffractometer with CuKa radiation. Totals of 896 and 1823 of independent reflections were collected for 2 and 4, respectively. The crystal structures were solved by the multi-solution method (MULTAN). The location of a bromine atom of 4 was determined by the heavy atom procedure. The positional parameters of nonhydrogen atoms were refined by the difference Fourie synthesis and the least-square method. Final refinement was performed by the block-diagonal least-square method with correction of anisotropic thermal parameters for non-hydrogen atoms and isotropic thermal parameters for hydrogen atoms. This gave R values of 0.037 and 0.106 for 2 and 4, respectively. The positional parameters are deposited with the Cambridge Crystallographic Data Center.
Enzyme Assay
The inhibitory activity against apricot emulsin and Trichoderma (3-glucosidase was measured as described previously18l. p-Nitrophenyl P-D-glucoside was used as a substrate. Preparation of rat epididymal a-mannosidase: Five adult Donryu rats were sacrified, and 4.4 g of epididymides were obtained. The tissue was cut into small pieces and homogenized in three volumes of saline. After incubation at 38°C for 1 hour, the autolyzed homogenate was kept at -20°C overnight, thawed at room temp, and centrifuged. The resulting supernatant was stored at 5°C, and used as a crude enzyme solution. The a-mannosidase activity was retained for at least a week.
Assay for a-Mannosidase-inhibitory Activity: The crude enzyme solution diluted 30 times with 0.1 M acetate buffer (pH 5.2) was used. A reaction mixture consisted of 0.5 ml of 0.005 M p-nitrophenyl a-D-mannoside, 1 ml of 0.1 M acetate buffer (pH 5.2) containing inhibitor and 0.5 ml of the diluted enzyme solution. After incubation for 30 minutes at 37°C, 5 ml of 0.1 M sodium carbonate were added and p-nitrophenol liberated was measured colorimetrically at 400 nm.
